Copyright Reports & Markets. All rights reserved.

Global Oncology/Cancer Drugs Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Oncology/Cancer Drugs Market Overview

      • 1.1 Product Overview and Scope of Oncology/Cancer Drugs
      • 1.2 Oncology/Cancer Drugs Segment by Type
        • 1.2.1 Global Oncology/Cancer Drugs Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Antimetabolite
        • 1.2.3 Alkaloid drugs
        • 1.2.4 Hormone
        • 1.2.5 Targeted drug
        • 1.2.6 Platinum-based drugs
        • 1.2.7 Other
      • 1.3 Oncology/Cancer Drugs Segment by Application
        • 1.3.1 Oncology/Cancer Drugs Consumption Comparison by Application (2014-2025)
        • 1.3.2 Blood Cancer
        • 1.3.3 Breast Cancer
        • 1.3.4 Gastrointestinal Cancer
        • 1.3.5 Prostate Cancer
        • 1.3.6 Respiratory/Lung Cancer
        • 1.3.7 Other
      • 1.4 Global Oncology/Cancer Drugs Market by Region
        • 1.4.1 Global Oncology/Cancer Drugs Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Oncology/Cancer Drugs Market Size
        • 1.5.1 Global Oncology/Cancer Drugs Revenue (2014-2025)
        • 1.5.2 Global Oncology/Cancer Drugs Production (2014-2025)

      2 Global Oncology/Cancer Drugs Market Competition by Manufacturers

      • 2.1 Global Oncology/Cancer Drugs Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Oncology/Cancer Drugs Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Oncology/Cancer Drugs Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Oncology/Cancer Drugs Production Sites, Area Served, Product Types
      • 2.5 Oncology/Cancer Drugs Market Competitive Situation and Trends
        • 2.5.1 Oncology/Cancer Drugs Market Concentration Rate
        • 2.5.2 Oncology/Cancer Drugs Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Oncology/Cancer Drugs Production Market Share by Regions

      • 3.1 Global Oncology/Cancer Drugs Production Market Share by Regions
      • 3.2 Global Oncology/Cancer Drugs Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Oncology/Cancer Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Oncology/Cancer Drugs Production
        • 3.4.1 North America Oncology/Cancer Drugs Production Growth Rate (2014-2019)
        • 3.4.2 North America Oncology/Cancer Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Oncology/Cancer Drugs Production
        • 3.5.1 Europe Oncology/Cancer Drugs Production Growth Rate (2014-2019)
        • 3.5.2 Europe Oncology/Cancer Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Oncology/Cancer Drugs Production (2014-2019)
        • 3.6.1 China Oncology/Cancer Drugs Production Growth Rate (2014-2019)
        • 3.6.2 China Oncology/Cancer Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Oncology/Cancer Drugs Production (2014-2019)
        • 3.7.1 Japan Oncology/Cancer Drugs Production Growth Rate (2014-2019)
        • 3.7.2 Japan Oncology/Cancer Drugs Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Oncology/Cancer Drugs Consumption by Regions

      • 4.1 Global Oncology/Cancer Drugs Consumption by Regions
      • 4.2 North America Oncology/Cancer Drugs Consumption (2014-2019)
      • 4.3 Europe Oncology/Cancer Drugs Consumption (2014-2019)
      • 4.4 China Oncology/Cancer Drugs Consumption (2014-2019)
      • 4.5 Japan Oncology/Cancer Drugs Consumption (2014-2019)

      5 Global Oncology/Cancer Drugs Production, Revenue, Price Trend by Type

      • 5.1 Global Oncology/Cancer Drugs Production Market Share by Type (2014-2019)
      • 5.2 Global Oncology/Cancer Drugs Revenue Market Share by Type (2014-2019)
      • 5.3 Global Oncology/Cancer Drugs Price by Type (2014-2019)
      • 5.4 Global Oncology/Cancer Drugs Production Growth by Type (2014-2019)

      6 Global Oncology/Cancer Drugs Market Analysis by Applications

      • 6.1 Global Oncology/Cancer Drugs Consumption Market Share by Application (2014-2019)
      • 6.2 Global Oncology/Cancer Drugs Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Oncology/Cancer Drugs Business

      • 7.1 Roche
        • 7.1.1 Roche Oncology/Cancer Drugs Production Sites and Area Served
        • 7.1.2 Oncology/Cancer Drugs Product Introduction, Application and Specification
        • 7.1.3 Roche Oncology/Cancer Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 HENGRUI
        • 7.2.1 HENGRUI Oncology/Cancer Drugs Production Sites and Area Served
        • 7.2.2 Oncology/Cancer Drugs Product Introduction, Application and Specification
        • 7.2.3 HENGRUI Oncology/Cancer Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 AstraZeneca
        • 7.3.1 AstraZeneca Oncology/Cancer Drugs Production Sites and Area Served
        • 7.3.2 Oncology/Cancer Drugs Product Introduction, Application and Specification
        • 7.3.3 AstraZeneca Oncology/Cancer Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 QILU
        • 7.4.1 QILU Oncology/Cancer Drugs Production Sites and Area Served
        • 7.4.2 Oncology/Cancer Drugs Product Introduction, Application and Specification
        • 7.4.3 QILU Oncology/Cancer Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Sanofi
        • 7.5.1 Sanofi Oncology/Cancer Drugs Production Sites and Area Served
        • 7.5.2 Oncology/Cancer Drugs Product Introduction, Application and Specification
        • 7.5.3 Sanofi Oncology/Cancer Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 HANSOH
        • 7.6.1 HANSOH Oncology/Cancer Drugs Production Sites and Area Served
        • 7.6.2 Oncology/Cancer Drugs Product Introduction, Application and Specification
        • 7.6.3 HANSOH Oncology/Cancer Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 LUYE
        • 7.7.1 LUYE Oncology/Cancer Drugs Production Sites and Area Served
        • 7.7.2 Oncology/Cancer Drugs Product Introduction, Application and Specification
        • 7.7.3 LUYE Oncology/Cancer Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Novartis
        • 7.8.1 Novartis Oncology/Cancer Drugs Production Sites and Area Served
        • 7.8.2 Oncology/Cancer Drugs Product Introduction, Application and Specification
        • 7.8.3 Novartis Oncology/Cancer Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 GuiZhou YiBai
        • 7.9.1 GuiZhou YiBai Oncology/Cancer Drugs Production Sites and Area Served
        • 7.9.2 Oncology/Cancer Drugs Product Introduction, Application and Specification
        • 7.9.3 GuiZhou YiBai Oncology/Cancer Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Lunan
        • 7.10.1 Lunan Oncology/Cancer Drugs Production Sites and Area Served
        • 7.10.2 Oncology/Cancer Drugs Product Introduction, Application and Specification
        • 7.10.3 Lunan Oncology/Cancer Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Eli Lilly and Company

      8 Oncology/Cancer Drugs Manufacturing Cost Analysis

      • 8.1 Oncology/Cancer Drugs Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Oncology/Cancer Drugs
      • 8.4 Oncology/Cancer Drugs Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Oncology/Cancer Drugs Distributors List
      • 9.3 Oncology/Cancer Drugs Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Oncology/Cancer Drugs Market Forecast

      • 11.1 Global Oncology/Cancer Drugs Production, Revenue Forecast
        • 11.1.1 Global Oncology/Cancer Drugs Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Oncology/Cancer Drugs Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Oncology/Cancer Drugs Price and Trend Forecast (2019-2025)
      • 11.2 Global Oncology/Cancer Drugs Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Oncology/Cancer Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Oncology/Cancer Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Oncology/Cancer Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Oncology/Cancer Drugs Production, Revenue Forecast (2019-2025)
      • 11.3 Global Oncology/Cancer Drugs Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Oncology/Cancer Drugs Consumption Forecast (2019-2025)
        • 11.3.2 Europe Oncology/Cancer Drugs Consumption Forecast (2019-2025)
        • 11.3.3 China Oncology/Cancer Drugs Consumption Forecast (2019-2025)
        • 11.3.4 Japan Oncology/Cancer Drugs Consumption Forecast (2019-2025)
      • 11.4 Global Oncology/Cancer Drugs Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Oncology/Cancer Drugs Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy and Others.
        Oncology Drugs is widely used For Blood Cancer, Breast Cancer, Gastrointestinal Cancer, Prostate Cancer, Respiratory/Lung Cancer and Other Cancer Treatment. The most proportion of Oncology Drugs used for Blood Cancer and the proportion in 2017 is 22.74%.

        The global Oncology/Cancer Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Oncology/Cancer Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Oncology/Cancer Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Roche
        HENGRUI
        AstraZeneca
        QILU
        Sanofi
        HANSOH
        LUYE
        Novartis
        GuiZhou YiBai
        Lunan
        Eli Lilly and Company

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Antimetabolite
        Alkaloid drugs
        Hormone
        Targeted drug
        Platinum-based drugs
        Other

        Segment by Application
        Blood Cancer
        Breast Cancer
        Gastrointestinal Cancer
        Prostate Cancer
        Respiratory/Lung Cancer
        Other

        Buy now